Leinco Technologies

Anti-Benzoylecgonine (BNG-0089)

Product Code:
 
LEI-B144
Product Group:
 
Primary Antibodies
Antibody Isotype:
 
Mouse IgG1 κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
BNG-0089
Regulatory Status:
 
RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Lateral-Flow Immunochromatographic Assay
Storage:
 
2-8°C
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-B144-1.0mg1.0 mg£281.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Concentration:
?1.0 mg/ml
Conjugate/Tag/Label:
Purified
Format:
Formulated in phosphate buffered saline, pH 7.2 and contains 0.05% sodium azide.
Formulation:
Formulated in phosphate buffered saline, pH 7.2 and contains 0.05% sodium azide.
Long Description:
Benzoylecgonine is a major metabolite of cocaine, a powerful stimulant drug derived from the coca plant. When cocaine is ingested, it is metabolized in the liver into various compounds, with benzoylecgonine being the primary metabolite that can be detected in urine. Unlike cocaine, benzoylecgonine has a longer half-life and can persist in the body for an extended period, making it a reliable marker for recent cocaine use. Consequently, drug tests often target benzoylecgonine to identify individuals who have used cocaine within a specific timeframe. This metabolite is frequently screened in workplace drug testing, forensic analyses, and legal situations to ascertain recent cocaine consumption, contributing to efforts aimed at detecting and addressing substance abuse.
Purity:
>98% by SDS Page
Target:
Benzoylecgonine

References

1. Nickley J, Pesce AJ, Krock K. Drug Test Anal. 9(8):1214-1216. (2017).